Literature DB >> 7488049

Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males.

H Osaka1, C Kawanishi, K Inoue, H Uesugi, K Hiroshi, K Nishiyama, Y Yamada, K Suzuki, S Kimura, K Kosaka.   

Abstract

We report a third mutation of the proteolipid protein gene in male Japanese patients with X-linked spastic paraplegia. Although the proteolipid protein gene encodes two myelin proteins, proteolipid protein and DM 20, our W144X mutation resides in the latter part of exon 3 (exon 3B), which is spliced out in DM 20. This mutation may reserve the function of DM 20. Findings in our patients support that this form of spastic paraplesia is allelic to Pelizaeus-Merzbacher disease and that the mild clinical phenotype of this disorder may be related to a mutation within exon 3B of the PLP gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488049     DOI: 10.1006/bbrc.1995.2539

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

Authors:  B Bilir; Z Yapici; C Yalcinkaya; I Baris; C M B Carvalho; M Bartnik; B Ozes; M Eraksoy; J R Lupski; E Battaloglu
Journal:  Clin Genet       Date:  2012-02-20       Impact factor: 4.438

2.  A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR.

Authors:  K Inoue; H Osaka; N Sugiyama; C Kawanishi; H Onishi; A Nezu; K Kimura; Y Yamada; K Kosaka
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication.

Authors:  J Takanashi; K Sugita; Y Tanabe; K Nagasawa; K Inoue; H Osaka; Y Kohno
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 4.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

5.  Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.

Authors:  Michael E Shy; Grace Hobson; Manisha Jain; Odile Boespflug-Tanguy; James Garbern; Karen Sperle; Wen Li; Alex Gow; Diana Rodriguez; Enrico Bertini; Pedro Mancias; Karen Krajewski; Richard Lewis; John Kamholz
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

6.  Insertion of mutant proteolipid protein results in missorting of myelin proteins.

Authors:  Catherine Vaurs-Barriere; Kondi Wong; Thais D Weibel; Mones Abu-Asab; Michael D Weiss; Christine R Kaneski; Tong-Hui Mixon; Simona Bonavita; Isabelle Creveaux; John D Heiss; Maria Tsokos; Ehud Goldin; Richard H Quarles; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

7.  Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.

Authors:  K Woodward; E Kendall; D Vetrie; S Malcolm
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 8.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

Review 9.  Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.

Authors:  Fredrik I Gruenenfelder; Gemma Thomson; Jacques Penderis; Julia M Edgar
Journal:  J Anat       Date:  2011-03-14       Impact factor: 2.610

10.  Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Authors:  Sietske H Kevelam; Jennifer R Taube; Rosalina M L van Spaendonk; Enrico Bertini; Karen Sperle; Mark Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A Sistermans; Geneviève Bernard; Coriene E Catsman-Berrevoets; Clara D M van Karnebeek; John R Østergaard; Richard L Friederich; Mahmoud Fawzi Elsaid; Jolanda H Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E Steenweg; Carola G M van Berkel; Quinten Waisfisz; Truus E M Abbink; Marjo S van der Knaap; Grace M Hobson; Nicole I Wolf
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.